Clinical Trials
- Heart/Cardiovascular
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
- Heart/Cardiovascular
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular, Endocrine System
Screening for Cardiac Amyloidosis Using Nuclear Imaging for Minority Populations (SCAN-MP)
- Ages60 years and older
- GenderBoth
- Heart/Cardiovascular
Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists (PROMPT-MRA)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Ertugliflozin in Acute Heart Failure
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes)
- Ages8 years and older
- GenderBoth
- Aging, Heart/Cardiovascular, Brain, Spinal Cord & Nervous System
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE)
- Ages75 years and older
- GenderBoth
- Lung, Diseases of the Respiratory Systems
Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Multimodal Outcome CHAracterization (MOCHA) in comatose cardiac arrest patients
- Ages18 years and older
- GenderBoth
- Orthopaedics, Muscle & Bone
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT)
- Ages40 years - 80 years
- GenderBoth